Marcin Radziwill - Medicover Chief Foundation

All Insiders . Germany . 
Stock . Medicover AB . Stakeholders . Insider . Marcin Radziwill
5M0B Stock  EUR 15.22  0.44  2.98%   

Insider

Marcin Radziwill is Chief Foundation of Medicover AB
Phone46 8 40 01 76 00
Webhttps://www.medicover.com

Medicover Management Efficiency

The company has return on total asset (ROA) of 0.024 % which means that it generated a profit of $0.024 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0261 %, meaning that it generated $0.0261 on every $100 dollars invested by stockholders. Medicover's management efficiency ratios could be used to measure how well Medicover manages its routine affairs as well as how well it operates its assets and liabilities.
Medicover AB has accumulated 375.8 M in total debt with debt to equity ratio (D/E) of 116.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Medicover AB has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Medicover until it has trouble settling it off, either with new capital or with free cash flow. So, Medicover's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medicover AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medicover to invest in growth at high rates of return. When we think about Medicover's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Isabelle MetrefRamsay Gnrale de
N/A
JeanMarc CoursierRamsay Gnrale de
N/A
Jerome BriceRamsay Gnrale de
N/A
Laurie HavanecCVS Health Corp
62
Pascal RocheRamsay Gnrale de
61
David FalkowskiCVS Health Corp
N/A
Olivier MissoffeRamsay Gnrale de
66
Karen LynchCVS Health Corp
60
Tilak MandadiCVS Health Corp
59
Georges IchkanianRamsay Gnrale de
N/A
Norman GreveCVS Health Corp
N/A
Larry McGrathCVS Health Corp
N/A
Jamel OuandaRamsay Gnrale de
47
Brigitte CachonRamsay Gnrale de
N/A
Alan MDCVS Health Corp
61
Pierre DuperatRamsay Gnrale de
54
Laurence PinotLacanRamsay Gnrale de
N/A
Shawn GuertinCVS Health Corp
59
Medicover AB provides diagnostic and healthcare services in Germany, Romania, Ukraine, Poland, Belarus, Moldova, Serbia, Turkey, Georgia, Bulgaria, India, and Hungary. Medicover AB was founded in 1995 and is headquartered in Stockholm, Sweden. MEDICOVER operates under Health Care Plans classification in Germany and is traded on Frankfurt Stock Exchange. It employs 20970 people. Medicover AB (5M0B) is traded on Frankfurt Exchange in Germany and employs 44,000 people.

Management Performance

Return On Equity0.0261
Return On Asset0.024

Medicover AB Leadership Team

Elected by the shareholders, the Medicover's board of directors comprises two types of representatives: Medicover inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medicover. The board's role is to monitor Medicover's management team and ensure that shareholders' interests are well served. Medicover's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medicover's outside directors are responsible for providing unbiased perspectives on the board's policies.
Hanna Bjellquist, Head Relations
Jaroslaw Urbanczyk, Chief Officer
Liselotte Bergmark, Group Human Resources Director
Fredrik Rgmark, CEO Director
Joe Ryan, Chief Officer
Staffan Ternstrom, Chief Services
Jenny Brandt, General Legal Counsel
John Stubbington, Managing Director, Healthcare Services
Marcin Radziwill, Chief Foundation
Andrew VallanceOwen, Chief Officer

Medicover Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medicover a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0261
Return On Asset0.024
Profit Margin0.01 %
Operating Margin0.04 %
Current Valuation2.94 B
Shares Outstanding71.58 M
Shares Owned By Insiders12.90 %
Shares Owned By Institutions45.17 %
Price To Earning46.07 X
Price To Book4.45 X

Currently Active Assets on Macroaxis

RSIRush Street Interactive
OKTAOkta Inc
BACBank of America
SSentinelOne
WDWalker Dunlop

Other Information on Investing in Medicover Stock

Medicover financial ratios help investors to determine whether Medicover Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicover with respect to the benefits of owning Medicover security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY